P

Inventor

THURKAUF ANDREW

US76 patents
⚠️ This page may combine multiple inventors who share the name “THURKAUF ANDREW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NEUROGEN CORP

42 patents
US5633376AMay 27, 1997

Certain aminomethyl phenylimidazole derivatives; and 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype ligands

NEUROGEN CORP57 citations96
US5212310AMay 18, 1993

Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands

NEUROGEN CORP89 citations96
US6569861B2May 27, 2003

Melanin concentrating hormone receptor ligands

NEUROGEN CORP33 citations93
US6172229B1Jan 9, 2001

1-phenyl-4-benzylpiperazines; dopamine receptor subtype specific ligands

NEUROGEN CORP26 citations93
US5859246AJan 12, 1999

1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands

NEUROGEN CORP27 citations93
US5817813AOct 6, 1998

Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands

NEUROGEN CORP24 citations93
US5681956AOct 28, 1997

4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands

NEUROGEN CORP29 citations93
US5625063AApr 29, 1997

Certain aryl fused imidazaopyrimidines; a new class of GABA brain receptor ligands

NEUROGEN CORP30 citations93
US5594141AJan 14, 1997

Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands

NEUROGEN CORP28 citations93
US5326868AJul 5, 1994

Certain aryl fused pyrrolopyrimidines; a new class of GABA brain receptor ligands

NEUROGEN CORP25 citations93
US5159083AOct 27, 1992

Certain aminomethyl phenylimidazole derivatives; a class of dopamine receptor subtype specific ligands

NEUROGEN CORP33 citations93
US6723743B1Apr 20, 2004

High affinity small molecule C5a receptor modulators

NEUROGEN CORP32 citations92
US6284761B1Sep 4, 2001

1-phenyl-4-(1-[2-aryl]cyclopropyl)methylpiperazines: dopamine receptor ligands

NEUROGEN CORP26 citations92
US6069251AMay 30, 2000

Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4- substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands

NEUROGEN CORP25 citations92
US5712392AJan 27, 1998

Certain 4-piperidine- and piperazinoalkyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands

NEUROGEN CORP21 citations92
US5633377AMay 27, 1997

4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligands

NEUROGEN CORP18 citations92
US5216159AJun 1, 1993

Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands

NEUROGEN CORP28 citations92
US6316470B1Nov 13, 2001

Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands

NEUROGEN CORP17 citations89
US6084098AJul 4, 2000

Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands

NEUROGEN CORP27 citations89
US6013650AJan 11, 2000

Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands

NEUROGEN CORP23 citations88
US7169775B2Jan 30, 2007

Amino methyl imidazoles as C5a receptor modulators

NEUROGEN CORP12 citations84
US6515133B1Feb 4, 2003

Pharmaceutical compositions containing certain diarylimidazole derivatives

NEUROGEN CORP16 citations84
US5656762AAug 12, 1997

4-piperidino-and piperazinomethyl-2-phenylimidazole derivatives, dopamine receptor subtype specific ligands

NEUROGEN CORP9 citations82
US5646280AJul 8, 1997

Substituted 4-(alkyl, dialkyl) or cycloaklyl)aminomethyl 2-phenylimidazoes: dopamine receptor subtype specific ligands

NEUROGEN CORP17 citations82
US7186734B2Mar 6, 2007

Aryl imidazoles and related compounds as C5a receptor modulators

NEUROGEN CORP6 citations74
US6797824B2Sep 28, 2004

Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands

NEUROGEN CORP4 citations74
US6753336B2Jun 22, 2004

Melanin concentrating hormone receptor ligands

NEUROGEN CORP7 citations74
US6544996B2Apr 8, 2003

1-phenyl-4-(1-[2-aryl]cyclopropyl) methylpiperazines: dopamine receptor ligands

NEUROGEN CORP8 citations74
US6426347B2Jul 30, 2002

1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands

NEUROGEN CORP4 citations74
US6358955B1Mar 19, 2002

Substituted imidazoles as subtype specific dopamine receptor ligands and pharmaceutical compositions containing such substituted imidazole

NEUROGEN CORP5 citations74
US6121260ASep 19, 2000

Method of treating conditions susceptible to modulation of NPY receptors with diarylimidazole derivatives

NEUROGEN CORP13 citations74
US5773616AJun 30, 1998

Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands

NEUROGEN CORP5 citations74
US5646279AJul 8, 1997

Substituted 4-piperazinylmethyl 2-phenylimidazoles; dopamine receptor subtype specific ligands

NEUROGEN CORP5 citations74
US5646281AJul 8, 1997

Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands

NEUROGEN CORP6 citations74
US5463054AOct 31, 1995

Certain aryl fused pyrrolopyrimidines; a new class of GABA brain receptor ligands

NEUROGEN CORP14 citations74
US6884815B1Apr 26, 2005

High affinity small molecule C5a receptor modulators

NEUROGEN CORP9 citations73
US6482844B1Nov 19, 2002

1-benzylimidazole derivatives

NEUROGEN CORP13 citations73
US5585490ADec 17, 1996

Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands

NEUROGEN CORP15 citations73
US6294530B1Sep 25, 2001

1-azatricyclic-4-benzylpiperazines

NEUROGEN CORP7 citations71
US6444819B1Sep 3, 2002

Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands

NEUROGEN CORP7 citations68
US6656943B2Dec 2, 2003

1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands

NEUROGEN CORP3 citations63
US6355644B1Mar 12, 2002

Benzylpiperazinyl-indolinylethanones

NEUROGEN CORP6 citations63

ACHILLION PHARMACEUTICALS INC

6 patents

NOVARTIS INT PHARM LTD

1 patent

SEARLE & CO

1 patent

Showing the top 50 of 76 patents by PatentIndex Score.